1. Home
  2. AMSC vs AGIO Comparison

AMSC vs AGIO Comparison

Compare AMSC & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Superconductor Corporation

AMSC

American Superconductor Corporation

HOLD

Current Price

$34.78

Market Cap

1.5B

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$27.53

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMSC
AGIO
Founded
1987
2007
Country
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AMSC
AGIO
Price
$34.78
$27.53
Analyst Decision
Strong Buy
Buy
Analyst Count
1
8
Target Price
$52.00
$36.63
AVG Volume (30 Days)
1.4M
865.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$32.83
$103.08
Revenue Next Year
$24.80
$126.67
P/E Ratio
$11.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.98
$22.24
52 Week High
$70.49
$46.00

Technical Indicators

Market Signals
Indicator
AMSC
AGIO
Relative Strength Index (RSI) 57.42 47.54
Support Level $31.05 $26.05
Resistance Level $35.50 $28.97
Average True Range (ATR) 3.36 1.18
MACD 0.73 0.06
Stochastic Oscillator 74.20 48.81

Price Performance

Historical Comparison
AMSC
AGIO

About AMSC American Superconductor Corporation

American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: